News Conference News ESC 2017 BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months Shelley Wood August 30, 2017
News Conference News ESC 2017 PURE Investigators: Rethink Diet Guidance to Plug More Fats, Fewer Carbs Shelley Wood August 29, 2017
News Conference News ESC 2017 VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost? Shelley Wood August 28, 2017
News Conference News ESC 2017 Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART Shelley Wood August 27, 2017
News Conference News ESC 2017 European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts Shelley Wood August 27, 2017
News Conference News ESC 2017 Underweight and Overlooked: Low BMI Patients May Be Highest-Risk Post-PCI Shelley Wood August 26, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017
News Daily News E-Cigarette Use in Youth Linked With Smoking Initiation, Escalation Shelley Wood August 17, 2017
News Daily News How Alcohol Hurts and Harms: CVD Sweet Spot Confirmed Anew in Large Meta-Analysis Shelley Wood August 15, 2017
News Daily News In Case of Emergency: Don’t Rely on ‘Normal’ Range Assays With DOACs Shelley Wood August 10, 2017
News Daily News FDA Deems ‘Field Action’ for Faulty IABPs a Class I Recall Shelley Wood August 07, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2017 Shelley Wood July 31, 2017
News Daily News New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device? Shelley Wood July 21, 2017
News Daily News Simple Frailty Test in TAVR Can Help Decide Not Just ‘If’ but ‘How’ Shelley Wood July 07, 2017
News Daily News US Lawmakers Urged India to Rethink Stent Price Cap Ahead of State Visit Shelley Wood June 27, 2017
News Conference News TVT 2017 Valve Leaflet Thrombosis: Treat It or Leave It Be? Shelley Wood June 19, 2017
News Conference News TVT 2017 Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial Shelley Wood June 16, 2017